Cesar A. Ortiz

Ribeirao Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia.

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia.

Journal: Cell reports. Medicine

Published: March 04, 2025

M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.

M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.

Journal: Science advances

Published: April 14, 2023

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Journal: British journal of haematology

Published: August 15, 2022

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.

Journal: Frontiers in oncology

Published: March 26, 2021

FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.

FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.

Journal: Oral diseases

Published: February 26, 2021

Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.

Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.

Journal: Cancers

Published: September 29, 2020

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.

Journal: Scientific reports

Published: January 07, 2020

Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression

Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression

Journal: Revista peruana de medicina experimental y salud publica

Published: April 25, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026